文献速递血栓与止血

黏弹性检测(TEG和ROTEM分析仪)在血友病新旧疗法管理中的临床效用

Clinical utility of viscoelastic testing (TEG and ROTEM analyzers) in the management of old and new therapies for hemophilia.
PubMed 文献 · Am J Hematol · 2018-12-07

血友病A和B分别由凝血因子VIII和IX缺乏所致,常规凝血及因子检测在管理临床表型和结局方面作用有限。本文综述黏弹性检测在血友病中的应用,包括临床表型判定、抑制物患者管理、围手术期管理及新型药物监测,并对其现有文献进行批判性评估。

要点

  • 常规凝血及因子检测在血友病临床表型和结局管理中作用有限。
  • 黏弹性检测在多种出血和血栓状态中已确立其效用。
  • 本综述评估黏弹性检测用于血友病表型、抑制物、围手术期及新药监测的文献。

核心结论

  • 黏弹性检测在血友病多个管理方面具有效用,包括临床表型判定、抑制物患者管理、围手术期管理和新型药物监测。

研究设计与样本

  • 综述,讨论并批判性评估关于黏弹性检测在血友病中应用的现有文献。

主要发现

  • 常规凝血和因子检测在血友病患者严重度分类和治疗监测中有用,但在管理临床表现和结局方面作用有限。
  • 黏弹性检测在多种出血和血栓状态中已确立其效用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hemophilia A and B are rare inherited bleeding disorders resulting from deficiency of coagulation factors VIII and IX respectively. In the past few decades, the field of hemophilia has witnessed pivotal management challenges and therapeutic advances. Routine coagulation and factor assays, while useful in the classification of severity and treatment monitoring in hemophilia patients, have been shown to be of limited use in managing clinical presentations and outcomes. This prompted the investigation of viscoelastic studies in hemophilia care, which have established their utility in various bleeding and thrombotic states. In this review, we will discuss and critically assess the current literature highlighting the use of viscoelastic studies in various aspects of hemophilia including the determination of clinical phenotype, management of patients with inhibitors, perioperative management, and monitoring of novel agents.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Ramiz S, Hartmann J, Young G, et al. Clinical utility of viscoelastic testing (TEG and ROTEM analyzers) in the management of old and new therapies for hemophilia. Am J Hematol. 2018. PMID: 30328141. doi:10.1002/ajh.25319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。